Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000150921 | SCV000198550 | likely benign | not specified | 2013-12-20 | criteria provided, single submitter | clinical testing | Ala238Ala in exon 7 of LDB3: This variant is not expected to have clinical signi ficance because it does not alter an amino acid residue and is not located withi n the splice consensus sequence. Ala238Ala in exon 7 of LDB3 (allele frequency = n/a) |
Gene |
RCV001719934 | SCV000524612 | likely benign | not provided | 2019-11-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000537866 | SCV000638677 | likely benign | Myofibrillar myopathy 4 | 2024-11-12 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000150921 | SCV001363755 | benign | not specified | 2019-07-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002362788 | SCV002662326 | likely benign | Cardiovascular phenotype | 2019-02-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |